Crossmark

Acceptable risks of treatments to prevent rheumatoid arthritis among first-degree relatives: demographic and psychological predictors of risk tolerance

Crossref DOI link: https://doi.org/10.1136/rmdopen-2022-002593

Published Online: 2022-12-13

Published Print: 2022-12

Update policy: https://doi.org/10.1136/crossmarkpolicy

Authors

Simons, Gwenda https://orcid.org/0000-0003-2596-9101
Janssen, Ellen M https://orcid.org/0000-0003-0405-4252
Veldwijk, Jorien https://orcid.org/0000-0003-4822-5068
DiSantostefano, Rachael L https://orcid.org/0000-0002-5324-6835
Englbrecht, Matthias

Radawski, Christine https://orcid.org/0000-0001-8487-6680
Valor-Méndez, Larissa https://orcid.org/0000-0002-4872-3502
Humphreys, Jennifer H https://orcid.org/0000-0003-2497-4080
Bruce, Ian N https://orcid.org/0000-0003-3047-500X
Hauber, Brett https://orcid.org/0000-0003-3129-7268
Raza, Karim https://orcid.org/0000-0003-1570-1232
Falahee, Marie https://orcid.org/0000-0001-5928-486X
Funding

Funding for this research was provided by:

Innovative Medicines Initiative (115966)
License Information

License valid from 2022-12-13